Suppr超能文献

高效表达具有催化活性的膜结合蛋白:人细胞色素 P450 氧化还原酶。

High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.

机构信息

Department of Pediatrics, University of California, HSE-1401, 513 Parnassus Avenue, San Francisco, San Francisco, California 94143-0978, USA.

出版信息

Endocrinology. 2011 Jul;152(7):2904-8. doi: 10.1210/en.2011-0230. Epub 2011 May 17.

Abstract

P450 oxidoreductase (POR) is a two-flavin protein that reduces microsomal P450 enzymes and some other proteins. Preparation of active bacterially expressed human POR for biochemical studies has been difficult because membrane-bound proteins tend to interact with column matrices. To reduce column-protein interactions and permit more vigorous washing, human POR lacking 27 N-terminal residues (N-27 POR) was modified to carry a C-terminal Gly3His6-tag (N-27 POR-G3H6). When expressed in Escherichia coli, N-27 POR-G3H6 could be purified to apparent homogeneity by a modified, single-step nickel-nitrilotriacetic acid affinity chromatography, yielding 31 mg POR per liter of culture, whereas standard purification of native N-27 POR required multiple steps, yielding 5 mg POR per liter. Both POR proteins had absorption maxima at 375 and 453 nm and both reduced cytochrome c with indistinguishable specific activities. Using progesterone as substrate for bacterially expressed purified human P450c17, the Michaelis constant for 17α-hydroxylase activity supported by N-27 POR or N-27 POR-G3H6 were 1.73 or 1.49 μm, and the maximal velocity was 0.029 or 0.026 pmol steroids per picomole P450 per minute, respectively. Using 17-hydroxypregnenolone as the P450c17 substrate, the Michaelis constant for 17,20 lyase activity using N-27 POR or N-27 POR-G3H6 was 1.92 or 1.89 μm and the maximal velocity was 0.041 or 0.042 pmol steroid per picomole P450 per minute, respectively. Thus, N-27 POR-G3H6 is equally active as native N-27 POR. This expression and purification system permits the rapid preparation of large amounts of highly pure, biologically active POR and may be generally applicable for the preparation of membrane-bound proteins.

摘要

细胞色素 P450 氧化还原酶(POR)是一种双黄素蛋白,可还原微粒体 P450 酶和其他一些蛋白质。由于膜结合蛋白往往与柱基质相互作用,因此制备用于生化研究的活性细菌表达的人 POR 一直很困难。为了减少柱蛋白相互作用并允许更剧烈的洗涤,缺乏 27 个 N 末端残基的人 POR(N-27 POR)被修饰为携带 C 末端 Gly3His6 标签(N-27 POR-G3H6)。当在大肠杆菌中表达时,N-27 POR-G3H6 可以通过改良的一步镍-亚氨基三乙酸亲和层析法纯化至明显的均一性,每升培养物产生 31 毫克 POR,而天然 N-27 POR 的标准纯化需要多个步骤,每升产生 5 毫克 POR。两种 POR 蛋白在 375nm 和 453nm 处均有吸收最大值,并且均以相同的比活性还原细胞色素 c。使用孕酮作为细菌表达的纯化人 P450c17 的底物,N-27 POR 或 N-27 POR-G3H6 支持的 17α-羟化酶活性的米氏常数分别为 1.73 或 1.49μm,最大速度分别为 0.029 或 0.026pmol 类固醇/皮摩尔 P450/分钟。使用 17-羟孕烯醇酮作为 P450c17 的底物,N-27 POR 或 N-27 POR-G3H6 用于 17,20 裂解酶活性的米氏常数分别为 1.92 或 1.89μm,最大速度分别为 0.041 或 0.042pmol 类固醇/皮摩尔 P450/分钟。因此,N-27 POR-G3H6 与天然 N-27 POR 一样具有活性。这种表达和纯化系统允许快速制备大量高纯度、生物活性的 POR,并且可能普遍适用于膜结合蛋白的制备。

相似文献

1
High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.
Endocrinology. 2011 Jul;152(7):2904-8. doi: 10.1210/en.2011-0230. Epub 2011 May 17.
2
Enhanced Purification of Recombinant Rat NADPH-P450 Reductase by Using a Hexahistidine-Tag.
J Microbiol Biotechnol. 2017 May 28;27(5):983-989. doi: 10.4014/jmb.1701.01028.
6
Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
J Clin Endocrinol Metab. 2009 Dec;94(12):4992-5000. doi: 10.1210/jc.2009-1460. Epub 2009 Oct 16.
9
Effect of histidine-tag and R457H and E580Q mutations on catalytic activity of recombinant human cytochrome P450 oxidoreductase.
Drug Metab Pharmacokinet. 2012;27(1):150-4. doi: 10.2133/dmpk.dmpk-11-nt-102. Epub 2011 Nov 29.

引用本文的文献

1
Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs.
J Inorg Biochem. 2023 Oct;247:112340. doi: 10.1016/j.jinorgbio.2023.112340. Epub 2023 Jul 24.
2
Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.
Drug Metab Dispos. 2022 Jan;50(1):49-57. doi: 10.1124/dmd.121.000642. Epub 2021 Oct 4.
4
Biophysical characterization of Aptenodytes forsteri cytochrome P450 aromatase.
J Inorg Biochem. 2018 Jul;184:79-87. doi: 10.1016/j.jinorgbio.2018.04.002. Epub 2018 Apr 7.
5
Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.
J Steroid Biochem Mol Biol. 2018 Jul;181:63-72. doi: 10.1016/j.jsbmb.2018.03.003. Epub 2018 Mar 13.
6
Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.
Drug Metab Dispos. 2017 Jun;45(6):635-645. doi: 10.1124/dmd.117.075317. Epub 2017 Apr 3.
8
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR.
J Biol Chem. 2016 Feb 19;291(8):3990-4003. doi: 10.1074/jbc.M115.677294. Epub 2015 Dec 30.
10
Epoxidation activities of human cytochromes P450c17 and P450c21.
Biochemistry. 2014 Dec 9;53(48):7531-40. doi: 10.1021/bi5011865. Epub 2014 Nov 25.

本文引用的文献

1
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
Pharmacogenet Genomics. 2010 Nov;20(11):677-86. doi: 10.1097/FPC.0b013e32833f4f9b.
2
Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Eur J Endocrinol. 2010 Dec;163(6):919-24. doi: 10.1530/EJE-10-0764. Epub 2010 Sep 15.
3
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.
Pharmacogenet Genomics. 2010 Oct;20(10):611-8. doi: 10.1097/FPC.0b013e32833e0cb5.
4
Human cytochrome p450c17: single step purification and phosphorylation of serine 258 by protein kinase a.
Endocrinology. 2010 Apr;151(4):1677-84. doi: 10.1210/en.2009-1247. Epub 2010 Feb 16.
5
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Pharmacogenet Genomics. 2008 Jul;18(7):569-76. doi: 10.1097/FPC.0b013e32830054ac.
6
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1733-8. doi: 10.1073/pnas.0711621105. Epub 2008 Jan 29.
7
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.
Mol Endocrinol. 2007 Oct;21(10):2579-95. doi: 10.1210/me.2007-0245. Epub 2007 Jun 26.
10
Minireview: regulation of steroidogenesis by electron transfer.
Endocrinology. 2005 Jun;146(6):2544-50. doi: 10.1210/en.2005-0096. Epub 2005 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验